Quantbot Technologies’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,887
Closed -$483K 1410
2018
Q4
$483K Buy
+16,887
New +$480K 0.05% 454
2018
Q2
Sell
-8,570
Closed -$213K 1660
2018
Q1
$213K Sell
8,570
-10,518
-55% -$256K 0.02% 678
2017
Q4
$462K Buy
19,088
+5,898
+45% +$155K 0.04% 523
2017
Q3
$364K Buy
13,190
+2,452
+23% +$65.4K 0.03% 552
2017
Q2
$269K Buy
+10,738
New +$266K 0.03% 586
2017
Q1
Sell
-3,795
Closed -$99K 1534
2016
Q4
$99K Buy
+3,795
New +$93.9K 0.01% 716
2016
Q2
Sell
-7,494
Closed -$112K 1506
2016
Q1
$112K Buy
7,494
+7,484
+74,840% +$125K 0.02% 697
2015
Q4
$0 Buy
+10
New +$186 ﹤0.01% 1524
2015
Q3
Sell
-13,795
Closed -$197K 1555
2015
Q2
$197K Buy
+13,795
New +$234K 0.04% 448

Other funds holding NXTM

Quantbot Technologies's NXTM Position: Q1 2019 in Review

Quantbot Technologies sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 16,887 shares — an estimated $483K sold.

Quantbot Technologies first reported a position in NXTM in Q2 2015 and held it in 9 quarters. The position peaked at $483K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Quantbot Technologies reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Quantbot Technologies sold 16,887 NxStage Medical Inc. shares in Q1 2019, an estimated $483K.
  • Quantbot Technologies first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 9 quarters.
  • Quantbot Technologies's NxStage Medical Inc. position peaked at $483K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Quantbot Technologies's 13F filing for Q1 2019, filed 13 May 2019.